{
    "id": "fac898b8-b3e7-4db5-a3ff-a3ebcdca84cf",
    "indications": {
        "text": "latanoprostene bunod ophthalmic solution , 0.024 % indicated reduction intraocular pressure ( iop ) patients open-angle glaucoma ocular hypertension .",
        "doid_entities": [
            {
                "text": "open-angle glaucoma (DOID:1067)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1067"
            },
            {
                "text": "glaucoma (DOID:1686)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1686"
            },
            {
                "text": "ocular hypertension (DOID:9282)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9282"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended one drop conjunctival sac affected eye ( ) daily evening . administer latanoprostene bunod ophthalmic solution , 0.024 % daily since shown frequent prostaglandin analogs may lessen intraocular pressure lowering effect . latanoprostene bunod ophthalmic solution used concomitantly topical ophthalmic products lower intraocular pressure , administer product least five ( 5 ) minutes apart .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "latanoprostene bunod ophthalmic solution , 0.024 % supplied low density polyethylene bottles dropper tips turquoise caps following sizes : 2.5 ml fill 4 ml white container - ndc 68083-563-01 5 ml fill 7 ml natural container - ndc 68083-564-01 storage : unopened bottle stored refrigerated 2\u00ba 8\u00bac ( 36\u00ba 46\u00baf ) . bottle opened may stored 2\u00ba 25\u00bac ( 36\u00ba 77\u00baf ) 8 weeks . shipment , bottles may maintained temperatures 40\u00b0c ( 104\u00b0f ) period exceeding 14 days . protect light . protect freezing .",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "LATANOPROSTENE BUNOD",
            "code": "I6393O0922",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_177703"
        },
        {
            "name": "BENZALKONIUM CHLORIDE",
            "code": "F5UM2KM3W7",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3020"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "EDETATE SODIUM",
            "code": "MP1J8420LU",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13404"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "organization": "Gland Pharma Limited",
    "name": "Latanoprostene Bunod Ophthalmic Solution, 0.024%",
    "effectiveTime": "20250502",
    "indications_original": "Latanoprostene bunod ophthalmic solution, 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.",
    "contraindications_original": "The recommended dosage is one drop in the conjunctival sac of the affected eye(s) once daily in the evening. Do not administer latanoprostene bunod ophthalmic solution, 0.024% more than once daily since it has been shown that more frequent administration of prostaglandin analogs may lessen the intraocular pressure lowering effect. If latanoprostene bunod ophthalmic solution is to be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure, administer each drug product at least five (5) minutes apart.",
    "warningsAndPrecautions_original": "Latanoprostene bunod ophthalmic solution, 0.024% is supplied in low density polyethylene bottles with dropper tips and turquoise caps in the following sizes: \u00a0 \u00a0 \u00a0 \u00a0 2.5 mL fill in a 4 mL white container - NDC 68083-563-01 \u00a0 \u00a0 \u00a0 \u00a0 5 mL fill in a 7 mL Natural container - NDC 68083-564-01\n                     Storage: Unopened bottle should be stored refrigerated at 2\u00ba to 8\u00baC (36\u00ba to 46\u00baF). Once a bottle is opened it may be stored at 2\u00ba to 25\u00baC (36\u00ba to 77\u00baF) for 8 weeks. During shipment, bottles may be maintained at temperatures up to 40\u00b0C (104\u00b0F) for a period not exceeding 14 days.\n                     Protect from light. Protect from freezing.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Latanoprostene Bunod Ophthalmic Solution, 0.024%",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_177703"
        }
    ]
}